Rend Al-Mondhiry spoke with Josh Long, Natural Products Insider, about the conflicting narratives lawmakers are hearing from the FDA and hemp industry stakeholders on the safety of CBD.
Rend stated, “It doesn’t seem like all of this information in its totality is being considered in these conclusions that the FDA is making.”
Read more on the subject in the full story here.
5185 MacArthur Blvd NW
Suite 230
Washington, D.C. 20016
PH:202.496.4966
515 South Flower Street
18th Floor
Los Angeles, CA 90071
PH:213.933.2330
The content in the Amin Wasserman Gurnani web site may constitute attorney advertising or advertising material within the meaning of applicable bar rules, and/or under the Rules of Professional Conduct governing lawyers. Nothing in this site is to be considered as either creating an attorney-client relationship between the reader and Amin Wasserman Gurnani or as the rendering of legal advice for any specific matter.
